AP5Z1

AP5Z1 encodes the ζ subunit of the adaptor protein complex 5 (AP-5), which physically associates with SPG11 (spatacsin) and SPG15 (spastizin) to govern endolysosomal membrane traffic and autophagic flux (PMID:20613862, PMID:30930081). AP-5 mediates retrograde trafficking from late endosomes to the trans-Golgi network and the recycling of lysosomes from autolysosomes; loss of AP5Z1 produces structural Golgi defects, impaired autophagic flux, accumulation of intracellular storage and autofluorescent material, and age-dependent degeneration of corticospinal axons (PMID:27606357, PMID:30930081). Lysosome trafficking directionality is set by competition between AP5Z1, which binds the retrograde dynein/dynactin subunit p150Glued, and spastizin, which binds the anterograde motor KIF13A, with spatacsin promoting lysosomal degradation of AP5Z1 to balance the two pools (PMID:37871017). Beyond its trafficking role, AP5Z1 recruits the E3 ligase TRIM21 to drive PTEN ubiquitination and activate PI3K/Akt/mTOR signaling in hepatocellular carcinoma cells (PMID:40394639), and its disruption sensitizes the non-canonical inflammasome in innate immune cells (PMID:41138668). AP5Z1 knockdown also reduces homologous-recombination double-strand break repair and sensitizes cells to DNA-damaging agents (PMID:20613862).

1. 2010 Medium

   Established that AP5Z1 is not an isolated protein but a stable partner of SPG11 and SPG15, defining a novel complex and linking it to a DNA double-strand break repair phenotype.

   Evidence Genome-scale esiRNA HR-DSBR screen plus co-IP/pulldown with SPG11 and SPG15 and drug-sensitivity assay in mutant cells

   PMID:20613862

   Open questions at the time

   • Mechanism connecting the complex to HR-DSBR not resolved
   • Helicase activity asserted but not biochemically demonstrated
   • Subunit stoichiometry and architecture undefined
2. 2016 Medium

   Showed that complete loss of AP5Z1 in patient cells causes lysosomal storage pathology, establishing a requirement for AP5Z1 in lysosomal homeostasis.

   Evidence Western blot, PAS staining, autofluorescence, and electron microscopy of fibroblasts from patients with biallelic AP5Z1 mutations

   PMID:27606357

   Open questions at the time

   • Molecular trafficking step responsible for storage not identified
   • Causal chain from storage to neurodegeneration unestablished
3. 2019 High

   Defined the trafficking step AP-5 acts on—late endosome-to-TGN transport and lysosome recycling from autolysosomes—and linked its failure to autophagy block and corticospinal axon degeneration.

   Evidence AP5Z1 knockout mouse with fibroblast trafficking and autophagic-flux assays, Golgi morphology analysis, and in vivo neuropathology

   PMID:30930081

   Open questions at the time

   • Direct cargo molecules of AP-5 not enumerated
   • How autophagy block translates specifically to corticospinal vulnerability unresolved
4. 2023 High

   Resolved how AP5Z1 levels and lysosome motility are controlled, showing spatacsin-driven degradation balances AP5Z1-dynein retrograde transport against spastizin-KIF13A anterograde transport.

   Evidence Reciprocal co-IP (AP5Z1-p150Glued, spastizin-KIF13A), degradation assays in brain extracts and MEFs, spatacsin knockdown/rescue, and live imaging of tubular lysosomes in cortical neurons

   PMID:37871017

   Open questions at the time

   • Degradation machinery acting on AP5Z1 not identified
   • Quantitative rules governing motor switching unknown
5. 2025 Medium

   Extended AP5Z1 function beyond trafficking into signaling, showing it recruits TRIM21 to ubiquitinate PTEN and activate PI3K/Akt/mTOR in liver cancer cells.

   Evidence Co-IP/MS identifying PTEN and TRIM21, PTEN ubiquitination Western blots, proliferation/apoptosis/autophagy assays, and animal models in hepatocellular carcinoma

   PMID:40394639

   Open questions at the time

   • Whether this signaling role requires the AP-5 complex or is AP5Z1-independent unclear
   • Direct versus bridged AP5Z1-TRIM21-PTEN interaction not dissected
   • Generality beyond HCC untested
6. 2025 Medium

   Connected the AP-5 complex to innate immunity, showing AP5Z1 disruption sensitizes the non-canonical inflammasome and that AP5 subunits are downregulated in activated Spg11-KO macrophages.

   Evidence Ap5z1 knockout mouse, inflammasome activation assays in microglia and BMDMs, mass spectrometry of activated BMDMs, and in vivo LPS challenge

   PMID:41138668

   Open questions at the time

   • Molecular mechanism linking AP-5 trafficking to inflammasome restraint unknown
   • Relevant cargo or membrane compartment not identified

• It remains unknown which membrane cargoes AP-5 selects and how a single complex coordinates endolysosomal trafficking, DNA repair, PI3K/Akt/mTOR signaling, and inflammasome control.
• Direct AP-5 cargo repertoire undefined
• Structural basis of subunit assembly unresolved
• Whether non-trafficking roles depend on the intact AP-5 complex untested